ALSE   $0.01  -99.83% Market Closed

Alseres Pharmaceuticals Inc
Total Cash 186.95K
totalCashPerShare
EBITDA -843.19K
Total Debt 8.92M
quickRatio 0.103
currentRatio 0.121
Total Revenue 473.73K
debtToEquity
Revenue/Share
ROA -2.4706101
ROE
grossProfits
freeCashflow -2.43M
operatingCashflow -1.34M
earningsGrowth
revenueGrowth 0.0
grossMargins 0.94611
ebitdaMargins -1.77989
operatingMargins -17.205019
profitMargins -1.6394099
enterpriseValue
forwardPE
floatShares
sharesOutstanding 6.13K
sharesShort 0.00
sharesShortPriorMonth 0.00
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.0
heldPercentInstitutions 0.0
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding
bookValue
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -776.64K
trailingEps -0.02%
forwardEps
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 0
lastUpdated Oct. 21, 2024, 2:48 p.m.